Deals In Brief / M&A: Living Well

Corporate Counsel

   | 0 Comments

Health care deals came fast and furious in April, with several multibillion-dollar transactions in the sector, including Nestlé SA's $11.85 billion agreement to buy Pfizer Inc.'s infant nutrition business [Deals & Suits, July]. Below, we list the advisers on three large health care deals signed in April and one signed in May, as well as on Roche Holding Ltd.'s abandoned effort to take over Illumina Inc.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to LexisAdvance®.

Continue to LexisAdvance®

Not a LexisAdvance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via LexisAdvance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202562611551

Thank you!

This article's comments will be reviewed.